CAPR Earnings Date: Nov 9, 2026 (Estimated) — Capricor Therapeutics, Inc.
NASDAQ · Healthcare · Biotechnology
Updated
When is CAPR's next earnings date?
Capricor Therapeutics, Inc. (CAPR) is expected to report Q3 2026 earnings on Monday, November 9, 2026 at 4:00 PM ET (after market close); the date is an estimate and has not been confirmed by the company. The consensus estimate is EPS of -$0.13 on revenue of $41.7M.
How did CAPR do in its last earnings report?
In its most recent report on Aug 14, 2026, Capricor Therapeutics, Inc. posted EPS of -$0.70 versus the -$0.59 estimate, a miss of 18.9%. The stock's 1-day post-earnings move was +77.0%.
How much does CAPR stock move after earnings?
CAPR beat EPS estimates in 1 of its last 8 reported quarters. Over the last 8 reports the stock moved an average of 23.6% (up or down) in the day after earnings.
About Capricor Therapeutics, Inc.
Capricor Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on the development of transformative cell and exosome-based therapeutics for treating Duchenne muscular dystrophy (“DMD”), a rare form of muscular dystrophy which results in muscle degeneration and premature death, and other diseases with unmet medical needs. Its product candidate consists of CAP-1002, Engineered Exosomes, CAP-2003, and Exosome-Based Vaccine. The company was founded on June 17, 1996 and is headquartered in San Diego, CA.
Earnings History
| Date | Period | EPS Est. | EPS Act. | Surprise | Revenue | Result | 1D Δ | 1W Δ | 1M Δ |
|---|---|---|---|---|---|---|---|---|---|
| 2026-08-14 | -0.59 | -0.70 | -18.87% | — | ❌ Miss | +76.96% | +62.35% | +109.26% | |
| 2026-08-13 | Q2 2026 | -0.58 | -0.70 | -20.69% | $0 | ❌ Miss | +57.96% | +62.35% | +109.26% |
| 2026-05-12 | Q1 2026 | -0.54 | -0.59 | -9.26% | $0 | ❌ Miss | -3.78% | -14.59% | -20.56% |
| 2026-03-12 | Q4 2025 | -0.53 | -0.62 | -16.98% | $0 | ❌ Miss | -8.74% | -6.73% | +3.35% |
| 2025-11-10 | Q3 2025 | -0.54 | -0.54 | +0.00% | $0 | ➖ Inline | +11.51% | +2.34% | +415.65% |
| 2025-08-11 | Q2 2025 | -0.48 | -0.57 | -18.75% | $0 | ❌ Miss | +2.88% | -1.47% | -19.00% |
| 2025-03-19 | Q4 2024 | -0.31 | -0.16 | +48.39% | $11.1M | ✅ Beat | +17.51% | +7.86% | -7.94% |
| 2024-11-13 | Q3 2024 | -0.36 | -0.38 | -5.56% | $2.3M | ❌ Miss | +9.34% | +11.89% | -21.58% |
Showing last 8 quarters.